Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Nicolet Bankshares
NIC
$3.43B
| $4.86M | ﹤0.01% |
29,408
-19,325
| -40% | -$2.85M |
|
|
MBX
1852
MBX Biosciences
MBX
$2.78B
| $4.85M | ﹤0.01% |
87,854
+76,016
| +642% | +$2.65M |
|
1853
Gold Fields
GFI
$32.8B
| $4.84M | ﹤0.01% |
144,113
+93,509
| +185% | +$3.89M |
|
1854
Lindblad Expeditions
LIND
$2.05B
| $4.84M | ﹤0.01% |
171,390
+24,282
| +17% | +$513K |
|
|
VOYG
1855
CALL
Voyager Technologies
VOYG
$1.88B
| $4.84M | ﹤0.01% |
+150,000
| New | +$5.19M |
|
1856
CALL
Chevron
CVX
$401B
| $4.84M | ﹤0.01% |
29,172
-120,828
| -81% | -$22.5M |
|
1857
Shift4
FOUR
$2.93B
| $4.83M | ﹤0.01% |
99,311
+8,357
| +9% | +$361K |
|
1858
Phinia Inc
PHIN
$2.21B
| $4.81M | ﹤0.01% |
58,380
-13,670
| -19% | -$1.05M |
|
|
BRSL
1859
Brightstar Lottery PLC
BRSL
$1.81B
| $4.81M | ﹤0.01% |
448,377
+367,330
| +453% | +$4.36M |
|
1860
CALL
IonQ
IONQ
$17.8B
| $4.79M | ﹤0.01% |
90,000
-202,600
| -69% | -$10.3M |
|
1861
Global Net Lease
GNL
$1.93B
| $4.79M | ﹤0.01% |
536,016
+5,509
| +1% | +$51.5K |
|
1862
Leonardo DRS
DRS
$9.8B
| $4.79M | ﹤0.01% |
112,157
+30,262
| +37% | +$1.34M |
|
|
GRAL
1863
GRAIL Inc
GRAL
$6.1B
| $4.78M | ﹤0.01% |
69,989
+8,673
| +14% | +$511K |
|
1864
Green Brick Partners
GRBK
$2.9B
| $4.78M | ﹤0.01% |
59,686
+11,978
| +25% | +$827K |
|
1865
PTC Therapeutics
PTCT
$5.42B
| $4.76M | ﹤0.01% |
58,370
+5,291
| +10% | +$382K |
|
|
MH
1866
McGraw Hill
MH
$2.41B
| $4.75M | ﹤0.01% |
502,081
+175,368
| +54% | +$2.11M |
|
1867
Iridium Communications
IRDM
$5.08B
| $4.75M | ﹤0.01% |
86,589
-907,480
| -91% | -$38.8M |
|
1868
Mattel
MAT
$3.78B
| $4.75M | ﹤0.01% |
342,093
-46,760
| -12% | -$684K |
|
1869
The Ensign Group
ENSG
$10.2B
| $4.75M | ﹤0.01% |
29,604
-78,811
| -73% | -$13.9M |
|
1870
Corvus Pharmaceuticals
CRVS
$989M
| $4.72M | ﹤0.01% |
315,749
+71,973
| +30% | +$999K |
|
1871
PUT
JD.com
JD
$35.5B
| $4.71M | ﹤0.01% |
+185,000
| New | +$5.45M |
|
|
OKLO
1872
CALL
Oklo
OKLO
$6.9B
| $4.71M | ﹤0.01% |
90,000
| – | – |
|
1873
Globus Medical
GMED
$10.2B
| $4.7M | ﹤0.01% |
59,533
-853
| -1% | -$72.5K |
|
|
ITWO
1874
ProShares Russell 2000 High Income ETF
ITWO
$186M
| $4.7M | ﹤0.01% |
100,000
| – | – |
|
1875
CALL
Boston Scientific
BSX
$63.6B
| $4.69M | ﹤0.01% |
109,800
-837,100
| -88% | -$45.5M |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.